glp 1 agonists and sglt2 inhibitors combination Combining glucagon-like peptide-1 receptor (GLP-1RAs) sodium-glucose cotransporter-2 (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology Full article: Combination SGLT2 inhibitor
Description
The same mechanisms that make GLP-1 receptor agonists effective, particularly delayed gastric emptying and altered gut motility, also create a predictable set of adverse effects and clinical presentations
Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea
And reducing stigma is critical if we want current and future medications for substance use disorders to have their full impact. The authors write that the effects of GLP-1RAs on alcohol use have been studied extensively
doi:10.3389/fendo.2019.00260 119
